IRON (Disc Medicine) Net Margin %: 0.00% (As of Mar. 2026)


IRON Disc Medicine Inc IRON
34 GF Score
Price $70.08
! 3 Warning Signs
View Full Analysis

What is Disc Medicine Net Margin %?

Disc Medicine IRON -0.30% 34 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates IRON with a GF Score™ of 34/100. The stock has 3 warning signs investors should review. Among 947 Biotechnology companies, Disc Medicine ranks worse than 105596.52% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Disc Medicine's Net Income for the three months ended in Mar. 2026 was $-63.50 Mil. Disc Medicine's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Disc Medicine's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Disc Medicine's Net Margin % or its related term are showing as below:


IRON's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.33
* Ranked among companies with meaningful Net Margin % only.

Disc Medicine  (NAS:IRON) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Disc Medicine Net Margin % Related Terms

Disc Medicine Net Margin % Historical Data

* Premium members only.

The historical data trend for Disc Medicine's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Disc Medicine Net Margin % Chart

Disc Medicine Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Disc Medicine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IRON vs DFTX, ARQT, MLYS: Net Margin % Comparison

For the Biotechnology subindustry, Disc Medicine's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Disc Medicine Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Disc Medicine's Net Margin % distribution charts can be found below:

* The bar in red indicates where Disc Medicine's Net Margin % falls into.


IRON
34GF Score
Disc Medicine Inc IRON
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Disc Medicine Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Disc Medicine's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-212.184/0
= %

Disc Medicine's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-63.504/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Disc Medicine (IRON) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Disc Medicine and its competitors. According to the industry distribution chart, Disc Medicine ranks #999999 out of 947 companies in the Biotechnology industry.
Is Disc Medicine's Net Margin % too high?
Disc Medicine's current Net Margin % is 0.00%. Based on the distribution chart, Disc Medicine ranks #999999 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Disc Medicine has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Disc Medicine's Net Margin % compare to DFTX and ARQT?
According to the Biotechnology industry distribution chart, Disc Medicine ranks #999999 out of 947 companies for Net Margin %. This places Disc Medicine in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Disc Medicine and its competitors. Disc Medicine's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Disc Medicine stock overvalued right now?
Disc Medicine (IRON) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Disc Medicine's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Disc Medicine (IRON), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Disc Medicine Business Description

Address 321 Arsenal Street, Suite 101, Watertown, MA, USA, 02472
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
34GF Score

Get the complete analysis for IRON

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$70.08
Price